Citations

Clear

7552 citation(s) found for "Ku, Matthew".

Knowledge, Values, and Preferences Regarding Contraceptive Choices Among Women Living With Inflammatory Bowel Disease
Limdi, Jimmy K. , Liu, Eleanor , Kuzhiyanjal, Anish John Kuriakose , Brookes, Matthew , Farraye, Jennifer , Cannon, Rachel, Rhodes, Sarah , Liu, Eleanor , Kuriakose Kuzhiyanjal, Anish J , Brookes, Matthew , Cannon, Rachel, Woodhams, Elisabeth J. , Farraye, Francis A.

Mayo Clinic

Journal of Crohn's and Colitis | November 27, 2024 | Volume: 19 | Issue: 5 | Pages: No page available

10.1093/ecco-jcc/jjae181 | PMID 39602552 Get It

Abstract Background and Aims Active inflammatory bowel disease (IBD) at conception is associated with adverse pregnancy outcomes. International guidelines address antenatal care, but contraception counseling and risk assessment are not addressed. Data on healthcare professionals’ guidance for women with IBD regarding contraception are scarce. We aimed to describe contraceptive use, preferences, knowledge, and barriers among women with IBD. Methods A 34-item questionnaire was administered to female IBD patients aged 18-45. Disease control was measured using PRO-2 and IBD-control questionnaire, and contraceptive preferences were assessed by the contraceptive features survey. Logistic regression explored associations between contraceptive use, attitudes, disease remission status, and other factors. Results Of 338 women surveyed, 243 (74%) used some form of contraception. Oral birth control pills (28%) and barrier methods (18%) were most used but 20% used long-acting methods. Women with active disease were more likely to use long-acting contraception (23%) compared to those in remission (17%). Contraceptive priorities were effectiveness (78%), ease of use (75%), and minimal side effects (68%). Only 25% women had discussed reproductive issues with their IBD clinician, though 85% were comfortable to do so. Preferred sources for reproductive counseling were IBD nurses (79%), general practitioners (75%), IBD doctors (68%), and gynecologists (49%). Conclusions A quarter of women with IBD were not using any contraception, and long-acting contraceptive use was low. Women prefer effective, easy-to-use contraceptives with minimal side effects but lack knowledge on effective contraception-related issues. Better education and proactive discussions between healthcare providers and patients could improve reproductive health in women with IBD.
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium
Day, Jonathan R , Koff, Jean L. , Wang, Yucai , Lossos, Izidore S. , Nastoupil, Loretta J. , Strouse, Christopher , Chihara, Dai , Martin, Peter , Leonard, John P. , Cohen, Jonathon B. , Ruan, Jia , Friedberg, Jonathan W. , Flowers, Christopher R. , Koff, Jean L , Wang, Yucai , Lossos, Izidore S , Nastoupil, Loretta J , Chihara, Dai , Cohen, Jonathon B , Kahl, Brad S , Burack, W Richard , Cerhan, James R , Link, Brian K , Maurer, Matthew , Casulo, Carla , Strouse, Christopher S , Larson, Melissa C. , Durani, Urshila , Habermann, Thomas M. , Martin, Peter, Kahl, Brad S. , Burack, Richard , Cerhan, James R. , Link, Brian K. , Maurer, Matthew J. , Casulo, Carla

Mayo Clinic

Blood Advances | November 27, 2024 | Volume: 9 | Issue: 5 | Pages: 1013-1023

10.1182/bloodadvances.2024014053 | PMID 39602301 Get It

Abstract Progression of disease within 24 months of initial immunochemotherapy (POD24) is a negative prognostic factor for patients with follicular lymphoma (FL). There is no standard treatment after POD24. Assembling an academic-based cohort from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence, we evaluated patterns of care and outcomes for 220 patients with FL with POD24 and retained FL histology. Therapy after POD24 was heterogeneous, with no treatment category accounting for >25% of the total. Among patients initially treated with bendamustine-rituximab, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone (R-CHOP) was the predominant second-line choice (48%). Among patients initially treated with R-CHOP, aggressive salvage therapy was the predominant second-line choice (38%). Overall response rate to therapy after POD24 was 64% (95% confidence interval [CI], 56-70); complete response rate was 39% (95% CI, 32-46). The median event-free survival for therapy after POD24 was 9.8 months (95% CI, 7.3-12.1); 5-year overall survival (OS) was 71% (95% CI, 65-78). OS was inferior for patients aged >70 years (hazard ratio [HR], 2.31; 95% CI, 1.27-4.20) and those with high-risk FL International Prognostic Index scores at diagnosis (HR, 2.10; 95% CI, 1.23-3.60). No treatment category stood out with more favorable results. Cause of death was predominantly lymphoma related. Patients with follicular histology at their POD24 event had a low cumulative incidence of transformation (1.1% at 5 years). Our study is among the largest cohorts describing contemporary patterns of care for patients with POD24, providing a focused data set useful for interpreting and designing prospective clinical trials in this population.
Neurohospitalist Core Competencies
Wold, Jana , Robertson, Jetter , Jeevarajan, Jerome , Knox, Molly G., Thatikunta, Prateek , Solorzano, Guillermo E., Galetta, Kristin , Dujari, Shefali , Goyal, Tarini , Ehrlich, Matthew , Donnelly, J., Marriott, Elizabeth , Mandge, Vishal , Dhoot, Roshni , Luedke, Matthew W. , Maas, Matthew B., Yu, Mei , Tolédano, Michel B. , Palaganas, Jamie L., Kvam, Kathryn A. , Dugue, Rachelle , Meltzer, Ethan , Touma, Lahoud , Shah, Maulik , Douglas, Vanja C. , Orjuela, Karen , Klein, Joshua P. , Likosky, David, Simpson, Jennifer , Richie, Megan , Dohle, Carolin, Morris, Jane G. , Gold, Carl A. , Maas, Matthew B. , Wold, Jana J , Ehrlich, Matthew E , Mustafa, Rafid , Kvam, Kathryn , Meltzer, Ethan , Shah, Maulik P , Orjuela, Karen , Klein, Joshua P , Gold, Carl A , Yu, Margaret Y., Toledano, Michel, Mustafa, Rafid , Palaganas, Jamie, Scott, Brian J.

Mayo Clinic

The Neurohospitalist | November 26, 2024 | Volume: 15 | Issue: 1 | Pages: 13-84

10.1177/19418744241297187 | PMID 39610897 Get It

The Neurohospitalist Core Competencies comprise a set of competency-based learning objectives that encapsulate the knowledge, skills, and attitudes of neurohospitalitists who specialize in the care of hospitalized patients with neurologic conditions. These competencies serve to characterize the rapidly expanding field of neurohospitalist medicine. The 27 chapters are divided into 3 sections entitled: neurological conditions, clinical interventions and interpretation of ancillary studies, and neurohospitalist role in the healthcare system. Each individual learning objective in the chapters describes a specific concept with an action verb to illustrate the behavior that the neurohospitalist exhibits. The individual neurohospitalist may not exhibit mastery in each of the topics included as individual practices vary in scope and practice pattern. A few examples of how the complete set of competencies may be used include in the creation of curricula for neurohospitalist fellowships, to assist in defining the scope of practice of neurohospitalists for administrative leaders of hospitals and departments, and in influencing the direction of further research and quality improvement in the field.
Spectral changes in motor thalamus field potentials during movement
Klassen, Bryan T. , Baker, Matthew , Jensen, Michael A. , Valencia, Gabriela Ojeda , Miller, Kai J. , Baker, Matthew R , Ojeda Valencia, Gabriela , Klassen, Bryan T , Jensen, Michael A

Mayo Clinic

Journal of Neurophysiology | November 26, 2024 | Volume: 133 | Issue: 1 | Pages: 101-108

10.1152/jn.00419.2024 | PMID 39589825 Get It

We studied movement-associated spectral changes in human motor thalamus and observed focal increases in broadband power with movement. This biomarker may be used as a tool for intraoperative functional mapping, DBS targeting, and closed-loop device control.
Diagnosing Allergic Contact Dermatitis Using Deep Learning: Single-Arm, Pragmatic Clinical Trial with an Observer Performance Study to Compare Artificial Intelligence Performance with Human Reader Performance
Carter, Rickey E. , Weston, Alexander D. , Wieczorek, Mikolaj A. , Fahad, Sheikh, Caruso, Maria A., Aristizabal, Miguel, Bruce, Alison J., Hall, Matthew R. , Aristizabal, Miguel A , Hall, Matthew R , Bruce, Charles J. , Carter, Rickey E , Pacheco-Spann, Laura M.

Mayo Clinic

Dermatitis® | November 26, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1089/derm.2024.0302 | PMID 39587877 Get It

Abstract: Background: Allergic contact dermatitis is a common, pruritic, debilitating skin disease, affecting at least 20% of the population. Objective: To prospectively validate a computer vision algorithm across all Fitzpatrick skin types. Methods: Each participant was exposed to 10 allergens. The reference criterion was obtained 5 days after initial patch placement by a board-certified dermatologist. The algorithm processed photographs of the test site obtained on Day 5. Human performance in reading the photographs was also evaluated. Results: A total of 206 evaluable participants [mean age 39 years, 66% (136/206) female, and 47% with Fitzpatrick skin types IV–VI] completed testing. Forty-two percent (87/206) of participants experienced 1 or more allergic reaction resulting in a total of 132 allergic reactions. The model provided high discrimination (AUROC 0.86, 95% CI: 0.82–0.90) and specificity (93%, 95% CI: 92%–94%) but with lower sensitivity (58%, 95% CI: 49%–67%). Human performance interpreting the photographs ranged from providing similar performance to the algorithm to providing superior performance when combined across readers. There were no serious adverse events. Conclusions: The combination of a smartphone capture of patch testing sites with deep learning yielded high discrimination across a diverse sample.
Vasculitic Myopathy
Pinto, Marcus Vinícius , Soontrapa, Pannathat , Naddaf, Elie , Pinto, Marcus V , Soontrapa, Pannathat , Naddaf, Elie , Warrington, Kenneth J. , Koster, Matthew J.

Mayo Clinic

Neurology | November 25, 2024 | Volume: 103 | Issue: 12 | Pages: No page available

10.1212/wnl.0000000000210141 | PMID 39586051 Get It

A Simple Clinical Predictive Model for Arthroscopic Mobility of Osteochondritis Dissecans Lesions of the Knee
Milewski, Matthew D., Milewski, Matthew D., Miller, Patricia E., Gossman, Emma C. , Coene, Ryan P. , Tompkins, Marc , Anderson, Christian N. , Bauer, Kathryn, Busch, Michael T., Carey, James L. , Ellermann, Jutta , Ellis, Henry B. , Erickson, John , Ganley, Theodore J. , Heyworth, Benton E. , Latz, Kevin, Lyon, Roger, Mayer, Stephanie W. , Milewski, Matthew D. , Milewski, Matthew D., Miller, Patricia E., Nepple, Jeffrey J. , Nguyen, Jie C. , Nissen, Carl W. , Paterno, Mark V. , Pennock, Andrew T. , Perkins, Crystal A. , Polousky, John D. , Saluan, Paul, Shea, Kevin G. , Wall, Eric J. , Willimon, Clifton, Wilson, Philip L., Wright, Rick W. , Zbojniewicz, Andy, Myer, Gregory D , Milewski, Matthew D., Milewski, Matthew D., Miller, Patricia E., Carsen, Sasha , Chambers, Henry G. , Edmonds, Eric W. , Fabricant, Peter D , Green, Daniel W , Hui, James Hoi Po , Kocher, Mininder Singh , Krych, Aaron J. , Milewski, Matthew D., Miller, Patricia E., Nelson, Bradley J. , Pace, J Lee , Weiss, Jennifer M., Wilson, Philip L. , Myer, Gregory D.

Mayo Clinic

The American Journal of Sports Medicine | November 25, 2024 | Volume: 52 | Issue: 14 | Pages: 3543-3550

10.1177/03635465241296133 | PMID 39584729 Get It

Background: Osteochondritis dissecans (OCD) of the knee is a focal idiopathic alteration of subchondral bone and/or its precursor with risk for instability and disruption of adjacent cartilage. Treatment options focused on preventing premature osteoarthritis vary depending on multiple patient and lesion characteristics, including lesion mobility. Purpose: To differentiate lesion mobility before arthroscopy using a multivariable model that includes patient demographic characteristics and physical examination findings. Study Design: Cohort study (Diagnosis); Level of evidence, 2. Methods: Demographic, preoperative physical examination, and radiographic data were collected from a multicenter national prospective cohort of patients with OCD of the knee. Inclusion criteria included patients <19 years of age and patients with arthroscopically confirmed mobility status based on the Research on Osteochondritis Dissecans of the Knee arthroscopy classification. Multivariable logistic regression analysis using stepwise model selection was used to determine factors associated with the likelihood of a mobile versus an immobile lesion. A 75% partition of the data was used for model training, and 25% was used as a validation cohort. Quantitative model fit statistics were computed using the holdout data, including sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC), along with the corresponding 95% CI. Results: A total of 407 patients in the prospective cohort met inclusion criteria, and 62% were male. The mean ± SD age was 13.7 ± 2.2 years, height 161.8 ± 5.3 cm, and weight 59.2 ± 42.2 kg. Arthroscopic evaluation yielded 235 immobile and 172 mobile lesions. Multivariable analysis determined that the best model to predict lesion mobility included chronologic age ≥14 years ( P < .001), effusion on physical examination ( P < .001), and any loss of range of motion on physical examination ( P = .07), while controlling for male sex ( P = .38) and weight >54.4 kg ( P = .12). In the 25% holdout validation sample (n = 102), a sensitivity of 83%, a specificity of 82%, and an AUC of 0.89 (95% CI, 0.82-0.95) were achieved with these predictive factors. Conclusion: Age, effusion, and loss of motion can predict knee OCD lesion mobility at the time of arthroscopy. Education about lesion mobility can help with surgical planning and patient and family counseling.
Conformation-specific RNA aptamers for phenotypic distinction between normal von Willebrand factor and type 2B von Willebrand disease
Machha, Venkata R. , Moon‐Tasson, Laurie, Tange, Julie I, Santiago-Davis, Annyoceli, Pruthi, Rajiv K. , Chen, Dong , Maher, L. James , Auton, Matthew , Tischer, Alexander , Moon-Tasson, Laurie, Tange, Julie, Chen, Dong , III, Louis James Maher , Auton, Matthew , Tischer, Alexander

Mayo Clinic

NAR Molecular Medicine | November 24, 2024 | Volume: 1 | Issue: 4 | Pages: No page available

10.1093/narmme/ugae021 | PMID 39719968 Get It

Abstract The A1 domain in Von Willebrand Factor (VWF) initiates coagulation through binding to platelet glycoprotein GPIbα receptors. Von Willebrand Disease (VWD)-Mutations in A1 that either impair (type 2M) or enhance (type 2B) platelet adhesion to VWF can locally destabilize and even misfold the domain. We leveraged misfolding in the gain-of-function type 2B VWD phenotype as a target, distinct from the normal conformation. Two nuclease-resistant 2′-fluoropyrimidine RNA aptamers were selected to discriminate normal A1 domains from a type 2B V1314D A1 variant in a glycosylated A1A2A3 tri-domain VWF-fragment. Two aptamers, W9 and V1, were isolated that selectively recognize, bind, and inhibit the A1–GPIbα interaction with WT A1A2A3 and V1314D A1A2A3, respectively. These aptamers were tested against their respective recombinant targets, plasma VWF, VWF concentrates, and patient plasma with the heterozygous type 2B VWD R1306W variant using clinical assays, surface plasmon resonance and inhibition assays of platelet adhesion to recombinant A1 and A1A2A3 domains under shear stress. The specificity of W9 and V1 aptamers confirms that pathological conformations of VWD Type 2B proteins are different from normal VWF. The availability of aptamers that distinguish normal plasma-derived VWF from VWD suggests potential applicability in clinical diagnosis of severe gain-of-function phenotypes.
Practice Advisory on the Implementation of Preoperative Anemia Management: The Society of Cardiovascular Anesthesiologists and the Society for the Advancement of Patient Blood Management
Burt, Jennifer M., Grant, Michael C. , Guinn, Nicole R. , Patel, Prakash A. , Popescu, Wanda M. , Raphael, Jacob , Salenger, Rawn , Shore‐Lesserson, Linda , Klompas, Allan M. , Hensley, Nadia B. , Warner, Matthew A.

Mayo Clinic

Anesthesia & Analgesia | November 22, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1213/ane.0000000000007321 | PMID 39671507 Get It

Preoperative anemia is common and associated with worse outcomes in cardiac surgery including acute kidney injury, red blood cell transfusion, cardiovascular complications, stroke, infection, and death. Patient blood management programs, which include dedicated clinical programs to diagnose and treat anemia in advance of surgery (ie, preoperative anemia programs), have been highlighted as a means to optimize the blood health of each patient, thereby decreasing risk for allogeneic transfusion and improving clinical outcomes. However, there remain implementation challenges for preoperative anemia programs, including difficulties with education of patients and staff, short lead times to address anemia, infrastructure and staffing limitations, lack of clear leadership or ownership of preoperative anemia, the need to develop treatment algorithms and ensure appropriate infusion therapy support, lack of capital support, and insurance/reimbursement concerns, amongst others. The purpose of this advisory from the Society of Cardiovascular Anesthesiologists (SCA) Clinical Practice Improvement Committee and the Subcommittee on Patient Blood Management with endorsement from the Society for the Advancement of Patient Blood Management (SABM) is to provide guidance on the development and implementation of a preoperative anemia clinic or service line, including identification and navigation through potential logistical barriers. A detailed analysis of financial incentives is highlighted in our companion article in this edition focuses on the return on investment of anemia management. Although originating with a focus on anemia before cardiac surgery, this advisory is broadly applicable to all perioperative patients.
Intraoperative Electrical Stapedius Reflex Testing to Monitor Cochlear Nerve Integrity during Simultaneous Vestibular Schwannoma Resection and Cochlear Implantation
Carlson, Matthew L. , Daher, Ghazal S. , Khandalavala, Karl R. , Lohse, Christine M. , Neff, Brian A., Driscoll, Colin L. W., Peris-Celda, Maria, Link, Michael J. , Saoji, Aniket A. , Peris‐Celda, Maria , Gompel, Jamie J. Van

Mayo Clinic

Otology & Neurotology | November 21, 2024 | Volume: 46 | Issue: 1 | Pages: 60-66

10.1097/mao.0000000000004379 | PMID 39666744 Get It

Objective To compare the utility of intraoperative electrically evoked auditory brainstem response (eABR) and electrically evoked stapedial reflex testing (eSRT) for cochlear nerve integrity monitoring during simultaneous translabyrinthine resection of vestibular schwannoma (VS) and cochlear implantation. Study design Historical cohort study. Setting Tertiary academic referral center. Patients Eleven patients (12 cases) who underwent translabyrinthine tumor resection with simultaneous placement of a standard, unmodified cochlear implant (CI). Intervention A CI placed at the beginning of the operation before tumor resection to facilitate intraoperative cochlear nerve monitoring through a CI-delivered electrical stimulus. Main outcome measure Correlation of intraoperative monitoring outcomes with postoperative CI performance. Results Among the 12 cases (median age, 47 years), eABR waveforms were present at the conclusion of tumor resection in 10, including 6 that achieved open set speech perception. Of the 2 cases with negative eABR, 1 achieved open set speech perception. By contrast, of the 8 cases with a positive eSRT response, 7 achieved open set speech perception. Of the 4 cases with a negative eSRT response, none achieved open set speech perception. The 3 cases that did not receive auditory stimulation included 2 with positive and 1 with negative eABR; all 3 had a negative eSRT response. Conclusions Intraoperative eSRT using an unmodified CI is a promising new method for monitoring the integrity of the cochlear nerve during simultaneous VS resection. eSRT response at the conclusion of tumor resection strongly correlated with CI open set speech capacity. Although still useful, eABR was less reliable at predicting postoperative hearing outcomes in this series.